Guardian Pharmacy Services, Stock Current Valuation
| GRDN Stock | 21.35 0.28 1.29% |
Valuation analysis of Guardian Pharmacy helps investors to measure Guardian Pharmacy's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Guardian Pharmacy's price fluctuation is not too volatile at this time. Calculation of the real value of Guardian Pharmacy is based on 3 months time horizon. Increasing Guardian Pharmacy's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Guardian Pharmacy is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Guardian Stock. However, Guardian Pharmacy's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 21.35 | Real 18.83 | Hype 21.33 | Naive 22.57 |
The intrinsic value of Guardian Pharmacy's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Guardian Pharmacy's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Guardian Pharmacy Services, helps investors to forecast how Guardian stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Guardian Pharmacy more accurately as focusing exclusively on Guardian Pharmacy's fundamentals will not take into account other important factors: Guardian Pharmacy Services, Company Current Valuation Analysis
Guardian Pharmacy's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Guardian Pharmacy Current Valuation | 1.29 B |
Most of Guardian Pharmacy's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Guardian Pharmacy Services, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Guardian Pharmacy Services, has a Current Valuation of 1.29 B. This is 91.03% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The current valuation for all United States stocks is 92.25% higher than that of the company.
Guardian Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guardian Pharmacy's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Guardian Pharmacy could also be used in its relative valuation, which is a method of valuing Guardian Pharmacy by comparing valuation metrics of similar companies.Guardian Pharmacy is currently under evaluation in current valuation category among its peers.
Guardian Fundamentals
| Profit Margin | (0.07) % | ||||
| Operating Margin | (0.33) % | ||||
| Current Valuation | 1.29 B | ||||
| Shares Outstanding | 9.2 M | ||||
| Shares Owned By Insiders | 0.96 % | ||||
| Shares Owned By Institutions | 99.04 % | ||||
| Number Of Shares Shorted | 753.91 K | ||||
| Price To Book | 9.80 X | ||||
| Price To Sales | 1.07 X | ||||
| Revenue | 1.05 B | ||||
| Gross Profit | 231.84 M | ||||
| EBITDA | (44.82 M) | ||||
| Net Income | 23.9 M | ||||
| Total Debt | 12.98 M | ||||
| Book Value Per Share | 2.02 X | ||||
| Cash Flow From Operations | 70.82 M | ||||
| Short Ratio | 8.66 X | ||||
| Earnings Per Share | (1.38) X | ||||
| Target Price | 24.33 | ||||
| Number Of Employees | 10 | ||||
| Market Capitalization | 1.25 B | ||||
| Total Asset | 271.17 M | ||||
| Working Capital | (8.41 M) | ||||
| Net Asset | 271.17 M |
About Guardian Pharmacy Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guardian Pharmacy Services,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardian Pharmacy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardian Pharmacy Services, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Guardian Pharmacy
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guardian Pharmacy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardian Pharmacy will appreciate offsetting losses from the drop in the long position's value.Moving against Guardian Stock
The ability to find closely correlated positions to Guardian Pharmacy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guardian Pharmacy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guardian Pharmacy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guardian Pharmacy Services, to buy it.
The correlation of Guardian Pharmacy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guardian Pharmacy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guardian Pharmacy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guardian Pharmacy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Guardian Pharmacy Piotroski F Score and Guardian Pharmacy Altman Z Score analysis. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Retail space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardian Pharmacy. If investors know Guardian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardian Pharmacy listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Guardian Pharmacy is measured differently than its book value, which is the value of Guardian that is recorded on the company's balance sheet. Investors also form their own opinion of Guardian Pharmacy's value that differs from its market value or its book value, called intrinsic value, which is Guardian Pharmacy's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardian Pharmacy's market value can be influenced by many factors that don't directly affect Guardian Pharmacy's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardian Pharmacy's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.